Foundry Partners, LLC Edwards Lifesciences Corp Transaction History

Foundry Partners, LLC

$1.84 Billion
Q2 2024

A detailed history of Foundry Partners, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Foundry Partners, LLC holds 3,550 shares of EW stock, worth $232,454. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,550

Previous 3,550 -0.0%

Holding current value

$232,454

Previous $339,000 3.54%

% of portfolio

0.02%

Previous 0.02%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$72.54 - $95.56 $14,870 - $19,589	-205 Reduced 5.46%	3,550 $339,000
Q3 2023 Nov 09, 2023	SELL	$69.28 - $93.38 $44,685 - $60,230	-645 Reduced 14.66%	3,755 $260,000
Q4 2022 Jan 30, 2023	SELL	$68.3 - $87.44 $74,720 - $95,659	-1,094 Reduced 19.91%	4,400 $328,000
Q3 2022 Oct 21, 2022	SELL	$82.37 - $107.29 $18,450 - $24,032	-224 Reduced 3.92%	5,494 $454,000
Q2 2022 Jul 28, 2022	SELL	$86.5 - $128.27 $340,637 - $505,127	-3,938 Reduced 40.78%	5,718 $544,000
Q3 2021 Oct 14, 2021	SELL	$102.91 - $122.75 $134,091 - $159,943	-1,303 Reduced 11.89%	9,656 $1.09 Million
Q2 2021 Jul 23, 2021	BUY	$83.84 - $104.76 $16,768 - $20,952	200 Added 1.86%	10,959 $1.14 Million
Q4 2020 Feb 04, 2021	BUY	$71.69 - $91.23 $143 - $182	2 Added 0.02%	10,759 $982,000
Q2 2020 Aug 03, 2020	BUY	$57.54 - $76.95 $384,712 - $514,487	6,686 Added 164.23%	10,757 $743,000
Q1 2020 May 08, 2020	SELL	$52.41 - $81.0 $7,180 - $11,097	-137 Reduced 3.26%	4,071 $768,000
Q4 2019 Feb 10, 2020	SELL	$71.7 - $82.09 $13,336 - $15,268	-186 Reduced 4.23%	4,208 $982,000
Q3 2019 Oct 23, 2019	SELL	$61.55 - $75.43 $39,207 - $48,048	-637 Reduced 12.66%	4,394 $966,000
Q2 2019 Jul 18, 2019	BUY	$55.74 - $64.41 $19,509 - $22,543	350 Added 7.48%	5,031 $929,000
Q1 2019 Apr 22, 2019	BUY	$47.89 - $64.05 $4,980 - $6,661	104 Added 2.27%	4,681 $896,000
Q4 2018 Jan 10, 2019	BUY	$46.41 - $56.94 $4,826 - $5,921	104 Added 2.27%	4,681 $717,000
Q4 2018 Jan 10, 2019	SELL	$46.41 - $56.94 $4,826 - $5,921	-104 Reduced 2.22%	4,577 $797,000
Q3 2018 Oct 17, 2018	BUY	$45.7 - $58.03 $73,851 - $93,776	1,616 Added 54.58%	4,577 $797,000
Q2 2018 Jul 19, 2018	SELL	$42.45 - $51.3 $2,886 - $3,488	-68 Reduced 2.24%	2,961 $431,000
Q1 2018 May 16, 2018	BUY	$37.19 - $47.45 $2,454 - $3,131	66 Added 2.23%	3,029 $423,000
Q4 2017 Jan 25, 2018	SELL	$33.79 - $39.39 $1,926 - $2,245	-57 Reduced 1.89%	2,963 $334,000
Q3 2017 Oct 31, 2017	BUY	$36.29 - $38.83 $109,595 - $117,266	3,020	3,020 $330,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Account

Foundry Partners, LLC Edwards Lifesciences Corp Transaction History